90 Days to Metabolic Change
Adiposano® has a remarkable and widespread affect on a broad list of inflammatory markers. Of particular interest to obesity experts is the simultaneous decrease of leptin while adiponectin is increased. This results in a 25%- 33% improvement of the Leptin/Adiponectin ratio over the course of 90 days.
These results were first observed in the Adiposano® Randomized Placebo-Controlled Trial conducted in Spain under the name Oralvisc®. These results were recently replicated in a series of case studies in Dallas, Texas.
How does Adiposano® work?
The mechanism of action of Adiposano has not been completely elucidated. Research suggests Adiposano® can inhibit adipogenesis (the creation of new fat cells), decrease pro-inflammatory cytokines, and decrease inflammation both systemically and in the synovial fluid. We believe that Adiposano® works block or restrict an upstream mechanism (perhaps CD44) which prevents a broad cascade of inflammatory response.